Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB737 Engrossed / Bill

Filed 03/11/2021

                     
 
ENGR. S. B. NO. 737 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED SENATE 
BILL NO. 737 	By: McCortney of the Senate 
 
  and 
 
  McEntire of the House 
 
 
 
 
[ Patient’s Right to Pharmacy Choice Act - power to 
investigate - powers of advisory committee - right of 
appeal - codification - effective date ] 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STAT E OF OKLAHOMA: 
SECTION 1.    AMENDATORY     Section 3, Chapter 426, O.S.L. 
2019 (36 O.S. Supp. 2020, Section 6960), is amen ded to read as 
follows: 
Section 6960. For purposes of the Patient’s Right to Pharmacy 
Choice Act: 
1.  “Health insurer” means any corporation, association, benefit 
society, exchange, partnership or individual licensed by the 
Oklahoma Insurance Code; 
2.  “Mail-order pharmacy” means a pharmacy licensed by th is 
state that primarily dispenses and delivers covered drugs vi a common 
carrier; 
3.  “Pharmacy benefits manager ” or “PBM” means a person that 
performs pharmacy benefits management and any other person acti ng 
for such person under a contractual or employmen t relationship in   
 
ENGR. S. B. NO. 737 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
the performance of pharmacy benefits manageme nt for a managed-care 
company, nonprofit hospital, medical service organization, insurance 
company, third-party payor or a health program admi nistered by a 
department of this state; 
4.  “Pharmacy and therapeutics committee” or “P&T committee” 
means a committee at a hospital or a health insurance plan that 
decides which drugs will appear on that entity ’s drug formulary; 
5.  “Provider” means a pharmacy, as defined in Section 353.1 of 
Title 59 of the Oklahoma Statutes, licensed by the State Board of 
Pharmacy or an agent or representative of a pharmacy including but 
not limited to the contracting agent of a pharmacy who dispenses 
prescription drugs o r devices to covered individuals; 
6. “Retail pharmacy network” means retail pharmacy providers 
contracted with a PBM in which the pharm acy primarily fills and 
sells prescriptions via a retail, storefront location; 
6. 7. “Rural service area” means a five-digit ZIP code in which 
the population density is less than one thousand (1,000) individuals 
per square mile; 
8.  “Spread pricing” shall mean the model of prescription drug 
pricing in which the pharmacy benefit manager charges a health 
benefit plan a contr acted price for prescription drugs, and the 
contracted price for th e prescription drugs differs from the amount 
the pharmacy benefit manager directly or indirectly pays the 
pharmacy or pharmacist for providing pharmacy services;   
 
ENGR. S. B. NO. 737 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
7. 9. “Suburban service area” means a five-digit ZIP code in 
which the population density is between one thousand (1,000) and 
three thousand (3,000) individuals per s quare mile; and 
8. 10. “Urban service area” means a five-digit ZIP code in 
which the population density is greater than three thousand (3,000) 
individuals per square mile. 
SECTION 2.     AMENDATORY     Section 5, Chapter 426, O.S.L. 
2019 (36 O.S. Supp. 2020, Section 6962), is amen ded to read as 
follows: 
Section 6962. A.  The Oklahoma Insurance Depart ment shall 
review and approve retail pharmacy network access for al l pharmacy 
benefits managers (PBMs) to ensure compliance with Section 4 of this 
act 6961 of this title. 
B.  A PBM, or an agent of a PBM, shall n ot: 
1.  Cause or knowingly permit the use of advertisement, 
promotion, solicitation, representation, proposal or offer that is 
untrue, deceptive or misleading; 
2.  Charge a pharmacist o r pharmacy a fee rela ted to the 
adjudication of a claim, including without limitation a fee for: 
a. the submission of a claim, 
b. enrollment or participation in a retail pharmacy 
network, or   
 
ENGR. S. B. NO. 737 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
c. the development or management of claims processing 
services or claims payment servi ces related to 
participation in a retail pharmacy network; 
3.  Reimburse a pharmacy or pharmaci st in the state an amount 
less than the amount that the PBM reimbur ses a pharmacy owned by or 
under common ownership with a PBM for providin g the same covered 
services.  The reimbursem ent amount paid to the phar macy shall be 
equal to the reimbursement amou nt calculated on a per-unit basis 
using the same generic product id entifier or generic code number 
paid to the PBM-owned or PBM-affiliated pharmacy; 
4.  Deny a pharmacy the opportunity to participate in any 
pharmacy network at preferred participation statu s if the pharmacy 
is willing to accept the terms and conditions tha t the PBM has 
established for other pharmacies as a condition of preferre d network 
participation status; 
5.  Deny, limit or terminate a pharmacy ’s contract based on 
employment status of any employee who has an active license to 
dispense, despite probation status, with the State Board of 
Pharmacy; 
6.  Retroactively deny or reduc e reimbursement for a covered 
service claim after returning a paid clai m response as part of the 
adjudication of the claim, unless: 
a. the original claim was submitted fraudulently, o r   
 
ENGR. S. B. NO. 737 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
b. to correct errors identified in an audit, so long as 
the audit was conducted in complianc e with Sections 
356.2 and 356.3 of Title 59 of the Oklahoma Statutes; 
or 
7.  Fail to make any p ayment due to a pharmacy or pharmacist for 
covered services properl y rendered in the event a PBM terminates a 
pharmacy or pharmacist from a pharmacy benefits man ager network; or 
8.  Conduct spread pricing, as defined in Section 6960 of this 
title, in this state. 
C.  The prohibitions under this sect ion shall apply to contr acts 
between pharmacy benefits managers and pharmacists or pharmacies for 
participation in ret ail pharmacy networks. 
1.  A PBM contract shall: 
a. not restrict, directly or indirectly, any p harmacy 
that dispenses a prescription drug from informing, or 
penalize such pharmacy for informing, an individual of 
any differential betwee n the individual’s out-of-
pocket cost or coverage with respect to acquisition of 
the drug and the amount an individu al would pay to 
purchase the drug directly, and 
b. ensure that any entity that provides pharmacy benefits 
management services under a contra ct with any such 
health plan or health insur ance coverage does not, 
with respect to such plan or coverage, restrict,   
 
ENGR. S. B. NO. 737 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
directly or indirectly, a pharmacy that di spenses a 
prescription drug from informing, or penalize such 
pharmacy for informing, a covered in dividual of any 
differential between the ind ividual’s out-of-pocket 
cost under the plan or coverage with respect to 
acquisition of the drug and the amount an i ndividual 
would pay for acquisition of the drug without using 
any health plan or health insurance coverage. 
2.  A pharmacy benefits manager ’s contract with a participating 
pharmacist or pharmacy shall not prohibit , restrict or limit 
disclosure of informati on to the Insurance Comm issioner, law 
enforcement or state and federal governmental officials 
investigating or examini ng a complaint or condu cting a review of a 
pharmacy benefits manager ’s compliance with the requ irements under 
the Patient’s Right to Pharmacy Choice Act. 
3.  A pharmacy benefits manager shall establish and maintain an 
electronic claim inquiry processing sy stem using the National 
Council for Prescription Drug Programs ’ current standards to 
communicate information to pharmacies submitting clai m inquiries. 
SECTION 3.    AMENDATORY     Section 8, Chapter 426, O.S.L. 
2019 (36 O.S. Supp. 2020, Section 6965), is amended to read as 
follows: 
Section 6965. A.  The Insurance Commissioner sha ll have power 
to examine and investigate into the affairs of every pharmacy   
 
ENGR. S. B. NO. 737 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
benefits manager (PBM) engaged in pharmacy benefits managem ent in 
this state in order to determine whether s uch entity is in 
compliance with the Patient’s Right to Pharmacy Choice Act. 
B.  All PBM files and records shall be subject to examination by 
the Insurance Commissioner or by duly appointed designees.  The 
Insurance Commissioner, au thorized employees and e xaminers shall 
have access to any of a PBM’s files and records that may relate to a 
particular complaint under investigation or to an inqui ry or 
examination by the Insurance Department. 
C.  Every officer, di rector, employee or agent of the PBM, upon 
receipt of any inquiry from the Commissione r shall, within thirty 
(30) twenty (20) days from the date the inquiry is sent, furnish the 
Commissioner with an adequate response to the inquiry. 
D.  When making an exa mination under this sectio n, the Insurance 
Commissioner may retain subject matter experts, attorneys, 
appraisers, independ ent actuaries, independent certified public 
accountants or an accou nting firm or individual holding a permit to 
practice public accoun ting, certified financial examiners or other 
professionals and specialists as examiner s, the cost of which shall 
be borne by the PBM which is the subject of the examination. 
SECTION 4.     AMENDATORY     Section 9, Chapter 426, O.S.L. 
2019 (36 O.S. Supp. 2020, Sec tion 6966), is amended t o read as 
follows:   
 
ENGR. S. B. NO. 737 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Section 6966. A.  The Insurance Commissioner shall p rovide for 
the receiving and processing of individual complaints al leging 
violations of the provisions of t he Patient’s Right to Pharmacy 
Choice Act. 
B.  The Commissioner shall establi sh a Patient’s Right to 
Pharmacy Choice Advisory Committee to advise the Commissioner and 
serve at his or her discretion.  The Advisory Com mittee shall review 
complaints, hold hearings, subpoena witnesses and rec ords, initiate 
prosecution, reprimand, place on probation, suspend, revoke and/or 
levy fines not to exceed Ten Thous and Dollars ($10,000.00) for each 
count for which alleging any pharmacy benefits manager (PBM) has 
violated a provision of this act the Patient’s Right to Pharmacy 
Choice Act.  The Advisory Committee may impose as part of any 
disciplinary action the payment of costs expended by the Insurance 
Department for any legal fees and costs including, but not limited 
to, staff time, salary and travel ex pense, witness fees and attorney 
fees.  The Advisory Committee may take such actions singly o r in 
combination, as the nature of the violation requires After review, 
the Advisory Committee shall make a recommendation to the 
Commissioner as to administrative action to be taken against the 
pharmacy benefits manager pursuant to subsections B and C of Section 
5 of this act. 
C.  The Advisory Committee shall consist of seven (7) persons 
appointed as follows:   
 
ENGR. S. B. NO. 737 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  Two persons who shall be nominated appointed by the Oklahoma 
Pharmacists Association; 
2.  Two consumer members not employed or related to insurance, 
pharmacy or PBM nominated appointed by the Office of the Governor; 
3.  Two persons representing the PBM or insurance industry 
nominated appointed by the Insurance Commissioner; an d 
4.  One person representing the Office of the Attorney General 
nominated appointed by the Attorney General. 
D.  Committee members shall be appointed for terms of five (5) 
years; provided, that of the members first appointed, the two 
members appointed by the Office of the Governor shall serve for one 
(1) year, the two members appointed by the Oklahoma Pharmacists 
Association shall serve for two (2) years, the two members appointed 
by the Insurance Commissioner shall serve for three (3) years and 
the one member appointed by the Attorney General shall serve for 
four (4) years.  The terms of the members of the Advisory Committee 
shall expire on the thirtieth day of Jun e of the year designated for 
the expiration of the term for which ap pointed, but the member shall 
serve until a qualified successor has been duly appointed.  No 
person shall be appointed to serve more than two consecutive terms. 
E.  Hearings shall be held in the Insurance Commissioner’s 
offices or at such other place as th e Insurance Commissioner may 
deem convenient.   
 
ENGR. S. B. NO. 737 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
F.  The Insurance Commissioner shall issue and serve upon the 
PBM a statement of the charges and a notice of hearing in accordance 
with the Administrative Procedures Act, Sections 250 through 323 of 
Title 75 of the Oklahoma Statutes. 
G.  At the time and place fixed for a hearing, the PBM shall 
have an opportunity to be heard and to show cause why the Insurance 
Commissioner or his or her duly app ointed hearing examiner should 
not revoke or suspend the PBM ’s license and levy administrative 
fines for each violation.  Upon good cause shown, the Commissioner 
shall permit any person to intervene, appear and be heard at the 
hearing by counsel or in pers on. 
H.  All hearings will be public and held in accordance with, and 
governed by, Sections 250 through 323 of Title 75 of the Oklahoma 
Statutes. 
I.  The Insurance Com missioner, upon written request reasonably 
made by the licensed PBM affected by the hearin g and at such PBM’s 
expense shall cause a full stenographic record o f the proceedings to 
be made by a competent court reporter. 
J.  If the Insurance Commissioner dete rmines, based on an 
investigation of complaints, that a PBM has engaged in violations of 
this act with such frequency as to indicate a general business 
practice and that such PBM should be subjected to closer supervision 
with respect to such practices, the Insurance Commissioner may   
 
ENGR. S. B. NO. 737 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
require the PBM to file a report at such periodic intervals as the 
Insurance Commissioner deems necessary. 
SECTION 5.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 6966.1 of Title 36, unless there 
is created a duplication in numbering, reads as follows: 
A.  The Insurance Commissioner may censure, suspend , revoke or 
refuse to renew a license of or levy a civil penalty against any 
person licensed under the insurance laws of this state for any 
violation of the Patient’s Right to Pharmacy Choice Act, Section 
6958 et seq. of Title 36 of the Oklahoma Statutes. 
B.  The license of a pharmacy benefits manager m ay be censured, 
suspended or revoked if the Commissioner finds, after notice and 
opportunity for a hearing, that the pharmacy benefits manager 
violated one or more provisions of the Patient’s Right to Pharmacy 
Choice Act. 
C.  In addition to or in lieu of any censure, suspension or 
revocation of a license, a pharmacy benefits ma nager may, after 
notice and opportunity for a hearing, be subject to a civil fine of 
not less than One Hundred Dollars ($100.00) and not greater than Ten 
Thousand Dollars ($10,000.00) for each violation.  The penalty may 
be enforced in the same manner in w hich civil judgments may be 
enforced. 
D.  The Commissioner shall be authorized to enforce the 
provisions of the Patient’s Right to Pharmacy Choice Act and impose   
 
ENGR. S. B. NO. 737 	Page 12  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
any penalty or remedy authorized under the act against a pharmacy 
benefits manager under inves tigation for or charged with a violation 
of the act or any provision of Title 36 of the Ok lahoma Statutes, 
notwithstanding whether the license of the pharmacy benefits manager 
has been surrendered or lapsed by operation of law. 
E.  1.  All hearings shall b e public and held in accordance with 
the Administrative Procedures Act. 
2.  Hearings shall be held at the office of the Insurance 
Commissioner or at any other place as the Commissione r may deem 
convenient. 
3.  The Commissioner, upon written request reasona bly made by 
the pharmacy benefits manager affected by the hearing, shall cause a 
full stenographic record of the proceedings to be made by a 
competent court reporter.  This record sha ll be at the expense of 
the pharmacy benefits manager. 
4.  The ordinary fees and costs of the hearing examiner 
appointed pursuant to Section 319 of Title 36 of the Oklahoma 
Statutes may be assessed by the hearing examiner against t he 
respondent unless the respondent is the prevailing party. 
F.  Any pharmacy benefits manage r whose license has been 
censured, suspended, revoked or denied renewal, or who has had a 
fine levied against him or her, shall have the right of appeal from 
the final order of the Commiss ioner, pursuant to Section 318 et seq. 
of Title 75 of the Oklahoma Statut es.   
 
ENGR. S. B. NO. 737 	Page 13  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
G.  If the Insurance Commissioner determines, based upon an 
investigation of complaint s, that a pharmacy benefits manager has 
engaged in violations of the provisions of the Patient’s Right to 
Pharmacy Choice Act with such frequency as to indicate a gen eral 
business practice, and that the pharmacy benefits manager should be 
subjected to closer supervision with respect to such practices, the 
Commissioner may require the pharmacy bene fits manager to file a 
report at any periodic intervals the Commissioner deems necessary. 
SECTION 6.  This act shall become effective November 1, 2021. 
Passed the Senate the 10th day of March, 2021. 
 
 
  
 	Presiding Officer of the Senate 
 
 
Passed the House of Representatives the ____ day of __________, 
2021. 
 
 
  
 	Presiding Officer of the House 
 	of Representatives